// App-Quantinova.ai

EP596 : RISK OF SERIOUS INFECTIONS IN PATIENTS WITH OR WITHOUT PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A REAL-WORLD MATCHED COHORT ANALYSIS

Researchers

Presenter

  • Bhumika J Patel

Principal Investigators

  • Richard Ofori-Asenso

  • Aijing Shang

  • Andy Surinach

  • Ari Alexandrou

  • Nadiesh Balachandran

  • Pablo Katz

  • Sasha Sreckovic

  • Jaroslaw Maciejewski

Medical Centers

  • Genesis Research, Hoboken, NJ, United States.

  • Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Roche Products Ltd., Welwyn Garden City, United Kingdom

Locations

  • United States

  • Switzerland

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Blood/haematological Diseases

Disease

  • Paroxysmal nocturnal hemoglobinuria

  • Aplastic anemia

  • Diabetes

  • Anemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved